Schneider et al. [46] isolated a leukemic stem cells (LSC)-enriched population from both NPM1mut and WT patients, and noted that the frequencies of CD34+CD38− cells in AML NPM1mut samples were significantly lower. This evidence concerns the gene CD34 and acute myeloid leukemia.